Akebia Therapeutics
AKBA
#6958
Rank
A$0.61 B
Marketcap
$2.95
Share price
4.02%
Change (1 day)
105.96%
Change (1 year)

Akebia Therapeutics (AKBA) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.38 Billion

According to Akebia Therapeutics's latest financial reports the company's total liabilities are A$0.38 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Akebia Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.39 B-22.48%
2022-12-31A$0.51 B-17.92%
2021-12-31A$0.62 B21.79%
2020-12-31A$0.51 B-4.09%
2019-12-31A$0.53 B5.04%
2018-12-31A$0.51 B65.36%
2017-12-31A$0.30 B-3.86%
2016-12-31A$0.32 B1864.2%
2015-12-31A$16.39 M93.95%
2014-12-31A$8.45 M92.81%
2013-12-31A$4.38 M-7.47%
2012-12-31A$4.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$126.58 B 32,723.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.24 B 23,559.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$164.20 B 42,478.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.40 B 3.82%๐Ÿ‡บ๐Ÿ‡ธ USA